Log In
BCIQ
Print this Print this
 

Neuropsychiatric EEG-Based Assessment Aid (NEBA) System

  Manage Alerts
Collapse Summary General Information
Company NEBA Health
DescriptionNon-invasive test that calculates the ratio of theta to beta brain wave frequencies
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentApproved
Standard IndicationNeurology, Diagnostic
Indication DetailsAssist in diagnosing attention deficit hyperactivity disorder (ADHD) in patients ages 6-17 years in combination with a complete medical and psychological examination
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today